Received Feb 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
lichenoid dermatitis; long term fatigue; This is a spontaneous report received from a Consumer or other non HCP. A 73-year-old female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "hypothyroidism" (unspecified if ongoing); "depression" (unspecified if ongoing); "Chronic fatigue/long hauler covid" (unspecified if ongoing); "Chronic fatigue/long hauler covid" (unspecified if ongoing); "insomnia" (unspecified if ongoing); "L ventricular regurgitation/coronary artery disease" (unspecified if ongoing); "L ventricular regurgitation/coronary artery disease" (unspecified if ongoing); "mild copd" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE taken for hypothyroidism; WELLBUTRIN taken for depression; TRINTELLIX taken for depression; ADDERALL taken for fatigue, post-acute covid-19 syndrome; CLONAZEPAN taken for insomnia; ASA taken for coronary artery disease, mitral valve incompetence. Past drug history included: Codeine for Drug allergy; Talwin for Drug allergy; Augmentin for Drug allergy; Zpak for Drug allergy; Erythromycin for Drug allergy; Lunesta for Drug allergy; Seroquel for Drug allergy. The following information was reported: LICHENOID KERATOSIS (non-serious), outcome "unknown", described as "lichenoid dermatitis"; FATIGUE (non-serious), outcome "unknown", described as "long term fatigue". The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500007634 same patient, product, event; different dose;
Medical History/Concurrent Conditions: Chronic fatigue; COPD; Coronary artery disease; Depression; Hypothyroidism; Insomnia; Long COVID; Mitral regurgitation
LEVOTHYROXINE; WELLBUTRIN; TRINTELLIX; ADDERALL; CLONAZEPAN; ASA